HALO
Halozyme Therapeutics, Inc. ยท Health Care ยท NASDAQ
$68.99
โฒ $0.44 (+0.64%)
Market cap
$8.1B
52-week range
$51.06 โ $82.22
Volume
1.1M
Previous close
$68.55
Halozyme Therapeutics, Inc. (HALO) is held by 3 tracked hedge fund(s) and traded by 2 member(s) of Congress. Sector: Health Care. Largest tracked holder: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
0.5% | 2.5M | $163M | โฒ 37% (+683K) | $67.30 | 2026-03-31 |
| SNYDER CAPITAL MANAGEMENT L P SNYDER CAPITAL MANAGEMENT L P |
2.9% | 2.3M | $150M | โผ 3.2% (โ76K) | $38.19 | 2026-03-31 |
| Stephens Investment Management Group LLC Stephens Investment Management Group LLC |
1.1% | 1.2M | $79M | โ | $38.19 | 2026-03-31 |
Related โพ
FAQ โพ
Which hedge funds hold HALO?
Tracked holders include: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, Stephens Investment Management Group LLC.
How much smart money owns HALO?
3 tracked hedge fund(s) and 2 member(s) of Congress have disclosed positions.
Are members of Congress trading HALO?
Yes โ 2 member(s) have disclosed HALO trades. See the Congress tab.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.